{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:29:16Z","timestamp":1789766956235,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T00:00:00Z","timestamp":1758412800000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000870","name":"John D. and Catherine T. MacArthur Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012298","name":"Allegheny Health Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012298","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000925","name":"John Templeton Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA015923"],"award-info":[{"award-number":["R01AA015923"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jpsychires.2024.08.044","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T16:08:20Z","timestamp":1725984500000},"page":"182-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Results from a randomized controlled trial of zonisamide in the treatment of alcohol use disorder"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6494-6829","authenticated-orcid":false,"given":"Todd J.","family":"Farchione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Spencer-Laitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0342-1687","authenticated-orcid":false,"given":"Marie","family":"Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren S.","family":"Woodard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7991-2755","authenticated-orcid":false,"given":"Andrew J.","family":"Curreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jpsychires.2024.08.044_bib1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamainternmed.2020.0249","article-title":"Efficacy of gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms: a randomized clinical trial","volume":"180","author":"Anton","year":"2020","journal-title":"JAMA Intern. Med."},{"issue":"4","key":"10.1016\/j.jpsychires.2024.08.044_bib2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/JCP.0b013e3181aba6a4","article-title":"Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms","volume":"29","author":"Anton","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2024.08.044_bib3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/JCP.0b013e3181db38bb","article-title":"Placebo-controlled trial of zonisamide for the treatment of alcohol dependence","volume":"30","author":"Arias","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2024.08.044_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1076\/clin.12.1.43.1726","article-title":"Hopkins verbal learning test \u2013 revised: normative data and analysis of inter-form and test-retest reliability","volume":"12","author":"Benedict","year":"1998","journal-title":"Clin. Neuropsychol."},{"issue":"3","key":"10.1016\/j.jpsychires.2024.08.044_bib5","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/jm101359c","article-title":"Interactions of monoamine oxidases with the antiepileptic drug Zonisamide: specificity of inhibition and structure of the human monoamine oxidase B complex","volume":"54","author":"Binda","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpsychires.2024.08.044_bib6","series-title":"Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS-5)","author":"Brown","year":"2014"},{"issue":"1","key":"10.1016\/j.jpsychires.2024.08.044_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1037\/0021-843X.110.1.49","article-title":"Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders","volume":"110","author":"Brown","year":"2001","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.jpsychires.2024.08.044_bib8","series-title":"Alcohol-related Disease Impact (ARDI)","year":"2022"},{"issue":"1\u20133","key":"10.1016\/j.jpsychires.2024.08.044_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2012.05.012","article-title":"Zonisamide up-regulated the mRNAs encoding astrocytic anti-oxidative and neurotrophic factors","volume":"689","author":"Choudhury","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpsychires.2024.08.044_bib10","doi-asserted-by":"crossref","first-page":"E305","DOI":"10.1111\/j.1530-0277.2012.01930.x","article-title":"Differences in the profiles of DSM-IV and DSM-5 alcohol use disorders: implications for clinicians","volume":"37","author":"Dawson","year":"2013","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.jpsychires.2024.08.044_bib11","article-title":"Delis-kaplan executive function system","author":"Delis","year":"2001","journal-title":"PsycTESTS Dataset"},{"key":"10.1016\/j.jpsychires.2024.08.044_bib12","first-page":"57","article-title":"Test review of Wide range achievement test\u2013fourth edition [review of the software Wide range achievement test\u2013fourth edition,","volume":"52","author":"Dell","year":"2008"},{"key":"10.1016\/j.jpsychires.2024.08.044_bib13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cct.2016.08.006","article-title":"An exploratory evaluation of Take Control: a novel computer-delivered behavioral platform for placebo-controlled pharmacotherapy trials for alcohol use disorder","volume":"50","author":"Devine","year":"2016","journal-title":"Contemp. Clin. Trials"},{"issue":"1\u20132","key":"10.1016\/j.jpsychires.2024.08.044_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.eplepsyres.2005.08.006","article-title":"Zonisamide at clinically relevant concentrations inhibits field EPSP but not presynaptic fiber volley in rat frontal cortex","volume":"67","author":"Huang","year":"2005","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.jpsychires.2024.08.044_bib15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.brainres.2005.05.005","article-title":"Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT1A receptor agonism","volume":"1049","author":"Ichikawa","year":"2005","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.jpsychires.2024.08.044_bib16","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1001\/archinte.168.11.1188","article-title":"Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial","volume":"168","author":"Johnson","year":"2008","journal-title":"Arch. Intern. Med."},{"issue":"18","key":"10.1016\/j.jpsychires.2024.08.044_bib17","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jpsychires.2024.08.044_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neulet.2010.06.058","article-title":"Zonisamide reduces cell death in SH-SY5Y cells via an anti-apoptotic effect and by upregulating MnSOD","volume":"481","author":"Kawajiri","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.jpsychires.2024.08.044_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/JCP.0000000000000246","article-title":"Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders","volume":"35","author":"Knapp","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.jpsychires.2024.08.044_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/00952991003674812","article-title":"Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependence","volume":"36","author":"Knapp","year":"2010","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.jpsychires.2024.08.044_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0924-9338(97)83296-8","article-title":"The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI","volume":"12","author":"Lecrubier","year":"1997","journal-title":"Eur. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2024.08.044_bib22","first-page":"343","article-title":"SAFTEE: a technique for the systematic assessment of side effects in clinical trials","volume":"22","author":"Levine","year":"1986","journal-title":"Psychopharmacol. Bull."},{"issue":"8","key":"10.1016\/j.jpsychires.2024.08.044_bib23","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1021\/jm970790w","article-title":"Structure\u2212activity studies on anticonvulsant sugar sulfamates related to Topiramate. Enhanced potency with cyclic sulfate derivatives","volume":"41","author":"Maryanoff","year":"1998","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.jpsychires.2024.08.044_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.35946\/arcr.v41.1.07","article-title":"Alcohol use disorder: the role of medication in recovery","volume":"41","author":"Mason","year":"2021","journal-title":"Alcohol Res. Curr. Rev."},{"issue":"22","key":"10.1016\/j.jpsychires.2024.08.044_bib25","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1021\/jm400894u","article-title":"Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-Chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112)","volume":"56","author":"McComsey","year":"2013","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.jpsychires.2024.08.044_bib26","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1176\/appi.ajp.2014.13121581","article-title":"Decreased prefrontal cortical dopamine transmission in alcoholism","volume":"171","author":"Narendran","year":"2014","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.08.044_bib27","article-title":"Alcohol's effects on health: drinking levels defined","year":"2023","journal-title":"National Institute on Alcohol Abuse and Alcoholism"},{"key":"10.1016\/j.jpsychires.2024.08.044_bib28","series-title":"Rethinking drinking: Alcohol and your health. NIH Publication No. 09-3770","year":"2009"},{"issue":"3","key":"10.1016\/j.jpsychires.2024.08.044_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0920-1211(95)00078-X","article-title":"Effects of zonisamide on dopaminergic system","volume":"22","author":"Okada","year":"1995","journal-title":"Epilepsy Res."},{"issue":"6","key":"10.1016\/j.jpsychires.2024.08.044_bib30","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/sj.bjp.0701941","article-title":"Interaction between Ca 2+, K +, carbamazepine and zonisamide on hippocampal extracellular glutamate monitored with a microdialysis electrode: effects of antiepileptic drugs on glutamate release","volume":"124","author":"Okada","year":"1998","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2024.08.044_bib31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12031-011-9638-8","article-title":"HRD1 levels increased by zonisamide prevented cell death and caspase-3 activation caused by endoplasmic reticulum stress in SH-SY5Y cells","volume":"46","author":"Omura","year":"2012","journal-title":"J. Mol. Neurosci."},{"issue":"23","key":"10.1016\/j.jpsychires.2024.08.044_bib32","doi-asserted-by":"crossref","first-page":"7528","DOI":"10.1021\/jm801432r","article-title":"Novel, broad-spectrum anticonvulsants containing a sulfamide group: advancement of N-((benzo[b]thien-3-yl)methyl)sulfamide (JNJ-26990990) into human clinical studies","volume":"52","author":"Parker","year":"2009","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.jpsychires.2024.08.044_bib33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/ajad.13061","article-title":"Zonisamide as an adjunctive treatment to cognitive processing therapy for veterans with posttraumatic stress disorder and comorbid alcohol use disorder: a pilot study","volume":"29","author":"Petrakis","year":"2020","journal-title":"Am. J. Addict."},{"issue":"2","key":"10.1016\/j.jpsychires.2024.08.044_bib34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00952990.2018.1528265","article-title":"State-of-the-art behavioral and pharmacological treatments for alcohol use disorder","volume":"45","author":"Ray","year":"2019","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"5","key":"10.1016\/j.jpsychires.2024.08.044_bib35","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/WNF.0b013e3181f0ed9a","article-title":"Effects of zonisamide in the treatment of alcohol dependence","volume":"33","author":"Rubio","year":"2010","journal-title":"Clin. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.jpsychires.2024.08.044_bib36","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1080\/13854046.2020.1730444","article-title":"Normative performance of older individuals on the Hopkins Verbal Learning Test-Revised (HVLT-R) according to ethno-racial group, gender, age and education level","volume":"35","author":"Ryan","year":"2020","journal-title":"Clin. Neuropsychol."},{"issue":"Suppl. 20","key":"10.1016\/j.jpsychires.2024.08.044_bib37","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"s5","key":"10.1016\/j.jpsychires.2024.08.044_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/j.1528-1157.2000.tb06046.x","article-title":"Concentration-effect studies with topiramate on selected enzymes and intermediates of the GABA shunt","volume":"41","author":"Sills","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpsychires.2024.08.044_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4612-0357-5_3","article-title":"Timeline follow-back","author":"Sobell","year":"1992","journal-title":"Measuring Alcohol Consumption"},{"issue":"2","key":"10.1016\/j.jpsychires.2024.08.044_bib40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.expneurol.2009.11.018","article-title":"The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance","volume":"221","author":"Sonsalla","year":"2010","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.jpsychires.2024.08.044_bib42","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/acer.12229","article-title":"The expression of KLF11 (tieg2), a monoamine oxidase B transcriptional activator in the prefrontal cortex of human alcohol dependence","volume":"38","author":"Udemgba","year":"2013","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"1\u20132","key":"10.1016\/j.jpsychires.2024.08.044_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(03)00183-9","article-title":"Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures","volume":"116","author":"Ueda","year":"2003","journal-title":"Mol. Brain Res."},{"issue":"46","key":"10.1016\/j.jpsychires.2024.08.044_bib44","doi-asserted-by":"crossref","first-page":"12700","DOI":"10.1523\/JNEUROSCI.3371-07.2007","article-title":"Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement","volume":"27","author":"Volkow","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpsychires.2024.08.044_bib45","series-title":"Wechsler Adult Intelligence Scale--Fourth Edition","author":"Wechsler","year":"2008"},{"key":"10.1016\/j.jpsychires.2024.08.044_bib46","series-title":"Wechsler Memory Scale","author":"Wechsler","year":"2009"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624005107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624005107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T17:20:49Z","timestamp":1730136049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395624005107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":45,"alternative-id":["S0022395624005107"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.08.044","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Results from a randomized controlled trial of zonisamide in the treatment of alcohol use disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.08.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}